Identifying causes of loss to follow up in newly diagnosed HIV-infected patients

Identifying causes of loss to follow up in newly diagnosed HIV-infected patients

Methods We retrospectively reviewed the clinical charts of the adult patients (P) who consulted for the first time in the Infectious Disease Clinic of the university associated hospital at Buenos Aires, Argentina, between June 1st 2005 and May 31st 2008. We identified between the P who were newly diagnosed with HIV infection, those who attended the clinic only once; we considered lose to follow...

Assessment at Antiretroviral Clinics during TB Treatment Reduces Loss to Follow-Up among HIV-Infected Patients

SETTING A South African township clinic where loss to follow-up during TB treatment may prevent HIV-infected TB patients from receiving life-saving ART. OBJECTIVE To determine factors associated with loss to follow-up during TB treatment. DESIGN Regression analyses of a cohort of ART-eligible TB patients who commenced TB treatment and were followed for 24 weeks. RESULTS Of 111 ART-eligibl...

Sero-prevalence of Cytomegalovirus and Toxoplasma Infections among Newly Diagnosed HIV Patients

Newly diagnosed incident dizziness of older patients: a follow-up study in primary care

BACKGROUND Dizziness is a common complaint of older patients in primary care, yet not much is known about the course of incident dizziness. The aim of the study was to follow-up symptoms, subjective impairments and needs of older patients (≥65) with incident dizziness and to determine predictors of chronic dizziness. Furthermore, we analysed general practitioners' (GPs') initial diagnoses, refe...

Six-year follow up of imatinib therapy for newly diagnosed chronic myeloid leukemia in Iranian patients.

BACKGROUND The present study reported a six-year follow up of patients with chronic myeloid leukemia who were on imatinib therapy. METHODS We performed a retrospective study on a total of 417 patients diagnosed with chronic-phase, Philadelphia-positive (Ph+) chronic myeloid leukemia within six months before study entry. Patients were eligible for the study if they were between 18 and 70 years...